CKD Bio Corp. — Investor Relations & Filings
CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2025.03) | 2025-05-15 | Korean | |
| 영업(잠정)실적(공정공시) | 2025-04-25 | Korean | |
| 투자판단관련주요경영사항 (티엠버스주200단위(클로스트리디움보툴리눔독소A형)제조판매 품목허가 신청) | 2025-04-09 | Korean | |
| 투자판단관련주요경영사항 (티엠버스주100단위(클로스트리디움보툴리눔독소A형) 제조판매 품목허가 승인) | 2025-04-01 | Korean | |
| 정기주주총회결과 | 2025-03-26 | Korean | |
| 감사보고서제출 | 2025-03-18 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
12 filings
| |||||
| 7902311 | 분기보고서 (2025.03) | 2025-05-15 | Korean | ||
| 7909605 | 영업(잠정)실적(공정공시) | 2025-04-25 | Korean | ||
| 7914120 | 투자판단관련주요경영사항 (티엠버스주200단위(클로스트리디움보툴리눔독소A형)제조판매 품목허가 신청) | 2025-04-09 | Korean | ||
| 7917292 | 투자판단관련주요경영사항 (티엠버스주100단위(클로스트리디움보툴리눔독소A형) 제조판매 품목허가 승인) | 2025-04-01 | Korean | ||
| 7921915 | 정기주주총회결과 | 2025-03-26 | Korean | ||
| 7952115 | 감사보고서제출 | 2025-03-18 | Korean | ||
| 7951151 | 사업보고서 (2024.12) | 2025-03-18 | Korean | ||
| 7968619 | 주주총회소집결의 | 2025-02-25 | Korean | ||
| 7968618 | 현금ㆍ현물배당결정 | 2025-02-25 | Korean | ||
| 7968162 | 주주총회소집공고 | 2025-02-25 | Korean | ||
| 7968092 | 의결권대리행사권유참고서류 | 2025-02-25 | Korean | ||
| 7989791 | 매출액또는손익구조30%(대규모법인은15%)이상변경 | 2025-01-24 | Korean | ||
|
2024
3 filings
| |||||
| 8005068 | 현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정 | 2024-12-13 | Korean | ||
| 8005038 | 주주명부폐쇄기간또는기준일설정 | 2024-12-13 | Korean | ||
| 8016564 | 분기보고서 (2024.09) | 2024-11-14 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CKD Bio Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16575/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16575 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16575 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16575 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16575}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CKD Bio Corp. (id: 16575)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.